Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regenxbio (RGNX) Total Non-Current Liabilities (2018 - 2025)

Regenxbio has reported Total Non-Current Liabilities over the past 8 years, most recently at $349.7 million for Q4 2025.

  • Quarterly results put Total Non-Current Liabilities at $349.7 million for Q4 2025, up 72.5% from a year ago — trailing twelve months through Dec 2025 was $349.7 million (up 72.5% YoY), and the annual figure for FY2025 was $349.7 million, up 72.5%.
  • Total Non-Current Liabilities for Q4 2025 was $349.7 million at Regenxbio, down from $363.1 million in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for RGNX hit a ceiling of $366.7 million in Q2 2025 and a floor of $178.3 million in Q4 2021.
  • Median Total Non-Current Liabilities over the past 5 years was $217.2 million (2022), compared with a mean of $248.2 million.
  • Biggest five-year swings in Total Non-Current Liabilities: skyrocketed 652.67% in 2021 and later tumbled 34.3% in 2022.
  • Regenxbio's Total Non-Current Liabilities stood at $178.3 million in 2021, then increased by 0.68% to $179.5 million in 2022, then rose by 21.88% to $218.7 million in 2023, then decreased by 7.33% to $202.7 million in 2024, then soared by 72.5% to $349.7 million in 2025.
  • The last three reported values for Total Non-Current Liabilities were $349.7 million (Q4 2025), $363.1 million (Q3 2025), and $366.7 million (Q2 2025) per Business Quant data.